tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Corvus Pharmaceuticals Inc

CRVS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
11.860USD
-0.680-5.42%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย 09/24, 14:33๏ผˆET๏ผ‰
997.31M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

CRVS ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Corvus Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
997.31M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-21.32
์ฃผ๋‹น์ˆœ์ด์ต
-0.56
์ˆ˜์ต
--
์ˆœ์ด์ต
-62.29M
ROE
-30.46%
ROA
-28.26%

Corvus Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 6, 2026
EPS / ์˜ˆ์ƒ
-0.19/-0.16
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-89.06%-0.19
-172.23%-0.15
12.91%-0.15
79.66%-0.12
-44.07%-0.10
281.18%0.21
-30.56%-0.18
-392.12%-0.60
47.86%-0.07
31.25%-0.12
35.67%-0.14
---0.12
---0.14
---0.17
---0.21
---0.68
----
----
----
----
์ˆœ์ด์ต
-124.54%-17.96M
-190.12%-13.69M
-1.72%-12.32M
74.74%-10.16M
-87.66%-8.00M
366.50%15.19M
-82.07%-12.11M
-570.28%-40.22M
34.46%-4.26M
27.59%-5.70M
32.22%-6.65M
59.54%-6.00M
22.24%-6.50M
5.11%-7.87M
-6.28%-9.82M
-38.96%-14.83M
28.84%-8.36M
28.35%-8.30M
-133.77%-9.24M
-8.95%-10.67M
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
--0.00%
--0.00%
--0.00%
----
----
----
----
์˜์—… ์ด์ต
-88.08%-19.30M
-49.94%-14.88M
-50.73%-12.22M
-45.72%-10.57M
-72.87%-10.26M
-58.68%-9.92M
-43.43%-8.11M
-30.49%-7.25M
-5.57%-5.94M
4.88%-6.25M
0.26%-5.65M
55.42%-5.56M
19.83%-5.62M
11.32%-6.57M
16.80%-5.67M
-37.87%-12.47M
37.88%-7.01M
35.44%-7.41M
31.07%-6.81M
8.11%-9.05M
์ˆœ์ด์ต
-124.54%-17.96M
-190.12%-13.69M
-1.72%-12.32M
74.74%-10.16M
-87.66%-8.00M
366.50%15.19M
-82.07%-12.11M
-570.28%-40.22M
34.46%-4.26M
27.59%-5.70M
32.22%-6.65M
59.54%-6.00M
22.24%-6.50M
5.11%-7.87M
-6.28%-9.82M
-38.96%-14.83M
28.84%-8.36M
28.35%-8.30M
-133.77%-9.24M
-8.95%-10.67M
์œ ๋™์ž์‚ฐ
191.59%220.97M
427.46%239.95M
7.00%58.21M
55.97%66.94M
57.03%75.78M
99.08%45.49M
94.62%54.41M
29.69%42.92M
27.30%48.26M
-35.72%22.85M
-35.97%27.96M
-35.45%33.09M
-35.62%37.91M
-44.77%35.55M
-38.77%43.66M
-34.90%51.27M
-14.81%58.88M
-6.46%64.37M
57.30%71.31M
49.99%78.76M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
60.75%13.67M
30.51%12.11M
-73.50%9.38M
-82.60%8.07M
-36.22%8.51M
38.08%9.28M
415.39%35.40M
535.79%46.41M
69.70%13.34M
-18.94%6.72M
-36.11%6.87M
-47.78%7.30M
-22.63%7.86M
-10.52%8.29M
10.94%10.75M
23.64%13.98M
-17.83%10.16M
-33.42%9.27M
-20.22%9.69M
-5.80%11.30M
์ด ์ž์‚ฐ
167.46%239.27M
325.98%253.19M
3.21%71.12M
36.83%80.47M
38.57%89.46M
48.28%59.44M
51.27%68.91M
13.23%58.81M
11.23%64.56M
-31.12%40.08M
-33.25%45.55M
-35.35%51.94M
-37.28%58.04M
-42.54%58.20M
-37.65%68.24M
-32.66%80.35M
-15.41%92.54M
-7.27%101.29M
27.97%109.45M
113.60%119.32M
๋ถ€์ฑ„ ์ด๊ณ„
51.05%13.95M
23.76%12.52M
-72.72%9.91M
-81.24%8.71M
-30.76%9.23M
50.49%10.11M
429.03%36.34M
506.38%46.41M
55.82%13.34M
-27.97%6.72M
-43.35%6.87M
-51.15%7.65M
-29.59%8.56M
-19.35%9.33M
-1.37%12.13M
10.53%15.67M
-6.44%12.15M
-22.11%11.57M
-8.13%12.29M
4.91%14.18M
์ž๋ณธ ์ด๊ณ„
180.86%225.33M
387.95%240.68M
87.93%61.20M
478.35%71.77M
56.62%80.23M
47.84%49.33M
-15.81%32.57M
-71.98%12.41M
3.52%51.23M
-31.72%33.36M
-31.06%38.68M
-31.53%44.29M
-38.44%49.48M
-45.54%48.87M
-42.25%56.12M
-38.49%64.68M
-16.61%80.39M
-4.94%89.72M
34.67%97.16M
148.28%105.15M
์ˆœ์˜์—…์ด์ต
-166.54%-15.40M
-25.55%-10.37M
-8.58%-9.19M
-51.34%-9.57M
-5.40%-5.78M
-60.23%-8.26M
-63.83%-8.46M
-16.32%-6.32M
-4.94%-5.48M
36.42%-5.16M
31.54%-5.17M
21.58%-5.43M
14.70%-5.22M
-26.26%-8.11M
-10.08%-7.55M
17.76%-6.93M
51.59%-6.12M
26.89%-6.42M
16.46%-6.86M
-8.96%-8.43M
์ˆœํˆฌ์ž
70.62%-5.96M
-3513.76%-144.85M
278.86%10.88M
32.70%-2.62M
-15.98%-20.30M
60714.29%4.24M
-162.42%-6.08M
-122.17%-3.89M
-308.11%-17.50M
-100.15%-7.00K
40.29%-2.32M
477.17%17.55M
-236.59%-4.29M
117.99%4.60M
-94.20%-3.88M
-12.42%3.04M
-79.40%3.14M
-627.73%-25.57M
-531.75%-2.00M
-65.08%3.47M
์ˆœ์žฌ๋ฌดํ™œ๋™
-99.54%166.00K
68267.74%190.75M
-99.89%20.00K
620.00%360.00K
17.78%35.77M
--279.00K
--18.61M
-85.07%50.00K
304.07%30.37M
-100.00%0.00
--0.00
--335.00K
--7.52M
--4.00K
-100.00%0.00
-100.00%0.00
----
----
-98.53%18.00K
28546.88%18.33M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Corvus Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 58.21M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 7.00์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Corvus Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 71.12M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 3.21์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Corvus Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 9.91M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -72.72์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Corvus Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 61.20M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 87.93์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Corvus Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -42.97M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -55.99์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Corvus Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” -7.80M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 71.63์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Corvus Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 36.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -25.70์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.19์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 81.05์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -15.28M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 75.47์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -32.60์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 81.36์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -21.83์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 79.95์ž…๋‹ˆ๋‹ค.

Corvus Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Corvus Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -42.97M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -55.99์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ